SAMHSA Proposed Rule: Medications For The Treatment Of Opioid Use Disorder

On December 16, 2022, the Substance Abuse and Mental Health Services Administration (SAMHSA) published this proposed rule to modify its regulations regarding medications for the treatment of opioid addiction. SAMHSA proposes to modify certain provisions of part 8 to update OTP accreditation and certification standards, treatment standards for the provision of
medications for opioid addiction as dispensed by Opioid Treatment Programs’ (OTPs), and requirements for individual practitioners eligible to dispense (including by prescribing) certain types of MOUD with a waiver under The Controlled  Substances Act (CSA) (21 U.S.C. 823(g . . .